167 related articles for article (PubMed ID: 17521331)
1. A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles.
Zaidi N; Herrmann T; Baechle D; Schleicher S; Gogel J; Driessen C; Voelter W; Kalbacher H
FEBS J; 2007 Jun; 274(12):3138-49. PubMed ID: 17521331
[TBL] [Abstract][Full Text] [Related]
2. A new selective substrate for cathepsin E based on the cleavage site sequence of alpha2-macroglobulin.
Yasuda Y; Kohmura K; Kadowaki T; Tsukuba T; Yamamoto K
Biol Chem; 2005 Mar; 386(3):299-305. PubMed ID: 15843176
[TBL] [Abstract][Full Text] [Related]
3. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D.
Yasuda Y; Kageyama T; Akamine A; Shibata M; Kominami E; Uchiyama Y; Yamamoto K
J Biochem; 1999 Jun; 125(6):1137-43. PubMed ID: 10348917
[TBL] [Abstract][Full Text] [Related]
4. Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity.
Baechle D; Cansier A; Fischer R; Brandenburg J; Burster T; Driessen C; Kalbacher H
J Pept Sci; 2005 Mar; 11(3):166-74. PubMed ID: 15635643
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease.
Zhou W; Scott SA; Shelton SB; Crutcher KA
Neuroscience; 2006 Dec; 143(3):689-701. PubMed ID: 16997486
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.
Cappiello MG; Wu Z; Scott BB; McGeehan GM; Harrison RK
Protein Expr Purif; 2004 Sep; 37(1):53-60. PubMed ID: 15294281
[TBL] [Abstract][Full Text] [Related]
7. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificity of cerebral cathepsin D and high-Mr aspartic endopeptidase.
Azaryan AV; Galoyan AA
J Neurosci Res; 1988 Feb; 19(2):268-71. PubMed ID: 3285013
[TBL] [Abstract][Full Text] [Related]
9. Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.
Lützner N; Kalbacher H
J Biol Chem; 2008 Dec; 283(52):36185-94. PubMed ID: 18957408
[TBL] [Abstract][Full Text] [Related]
10. Exploring the binding preferences/specificity in the active site of human cathepsin E.
Rao-Naik C; Guruprasad K; Batley B; Rapundalo S; Hill J; Blundell T; Kay J; Dunn BM
Proteins; 1995 Jun; 22(2):168-81. PubMed ID: 7567964
[TBL] [Abstract][Full Text] [Related]
11. Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity.
Barbey C; Watts C; Corradin G
Eur J Immunol; 1995 Jan; 25(1):30-6. PubMed ID: 7843248
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic activation of internalized cholera toxin within hepatic endosomes by cathepsin D.
Merlen C; Fayol-Messaoudi D; Fabrega S; El Hage T; Servin A; Authier F
FEBS J; 2005 Sep; 272(17):4385-97. PubMed ID: 16128808
[TBL] [Abstract][Full Text] [Related]
13. Recombinant cathepsin E has no proteolytic activity at neutral pH.
Zaidi N; Herrmann T; Voelter W; Kalbacher H
Biochem Biophys Res Commun; 2007 Aug; 360(1):51-5. PubMed ID: 17577573
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation.
Igarashi S; Takizawa T; Takizawa T; Yasuda Y; Uchiwa H; Hayashi S; Brysk H; Robinson JM; Yamamoto K; Brysk MM; Horikoshi T
Br J Dermatol; 2004 Aug; 151(2):355-61. PubMed ID: 15327542
[TBL] [Abstract][Full Text] [Related]
15. Characterization of rat cathepsin E and mutants with changed active-site residues and lacking propeptides and N-glycosylation, expressed in human embryonic kidney 293T cells.
Tsukuba T; Ikeda S; Okamoto K; Yasuda Y; Sakai E; Kadowaki T; Sakai H; Yamamoto K
FEBS J; 2006 Jan; 273(1):219-29. PubMed ID: 16367762
[TBL] [Abstract][Full Text] [Related]
16. Endolysosomal transport of newly-synthesized cathepsin D in a sucrose model of lysosomal storage.
Hamer I; Jadot M
Exp Cell Res; 2005 Oct; 309(2):284-95. PubMed ID: 16055118
[TBL] [Abstract][Full Text] [Related]
17. Aspartic cathepsin D degrades the cytosolic cysteine cathepsin inhibitor stefin B in the cells.
Železnik TZ; Kadin A; Turk V; Dolenc I
Biochem Biophys Res Commun; 2015 Sep; 465(2):213-7. PubMed ID: 26239660
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D immobilized capillary reactors for on-flow screening assays.
Cornelio VE; de Moraes MC; Domingues VC; Fernandes JB; da Silva MFDGF; Cass QB; Vieira PC
J Pharm Biomed Anal; 2018 Mar; 151():252-259. PubMed ID: 29367161
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the posttranslational processing of a lysosomal enzyme in C6 glioma cells.
Snyder DS; Whitaker JN
J Neurosci Res; 1988 May; 20(1):73-83. PubMed ID: 3047414
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a membrane-associated cathepsin D-like enzyme from the model antigen presenting cell, A20, and its ability to generate antigenic fragments from a protein antigen in a cell-free system.
Williams KP; Smith JA
Arch Biochem Biophys; 1993 Sep; 305(2):298-306. PubMed ID: 8103981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
